Necroptosis-related lncRNAs: biomarkers for predicting prognosis and immune response in lung adenocarcinoma
Necro-related lnc can affect disease progression and patient prognosis. In addition, these lncRNAs can be used to design therapeutic strategies, such as immunotherapy, to treat patients with LUAD.
Authors
- Luhao Liu (ORCID: https://orcid.org/0009-0001-5584-0109)
- Kunpeng Lin
- Zhijun Xie (ORCID: https://orcid.org/0000-0002-9268-4029)
- Taisheng Liu (ORCID: https://orcid.org/0000-0002-0132-4707)
- Taichiro Goto (ORCID: https://orcid.org/0000-0002-2560-3639)
- Chenggong Wei
- Katsuhiro Okuda (ORCID: https://orcid.org/0000-0003-0099-2348)
- Chunxuan Lin
- Yingying Zhang (ORCID: https://orcid.org/0000-0003-0056-5274)
- Yoshihisa Shimada (ORCID: https://orcid.org/0000-0003-3811-6159)
- Xiaochun Lin
- Yong Dai
- Hai Yuan
Institutions
- Tokyo Medical University (JP)
- Second Affiliated Hospital of Guangzhou Medical University (CN)
- Nanfang Hospital (CN)
- Guangzhou Medical University Cancer Hospital (CN)
- Yamanashi Prefectural Central Hospital (JP)
- Southern Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Translational Lung Cancer Research
- Published
- 2024-10-01
- DOI
- https://doi.org/10.21037/tlcr-24-627
- Citations
- 3
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.86
Funders
- Medical Science and Technology Foundation of Guangdong Province